Research Nester published a report titled “Cognitive Neuroscience Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global cognitive neuroscience market in terms of market segmentation by type, application, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global cognitive neuroscience market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2022 – 2031. The market is segmented on the basis of application into brain imaging, neurological research, neurological disorders, psychiatry, and others. Out of these, the neurological research segment is anticipated to hold a substantial share over the forecast period, on account of the growing need for new treatment methods for various mental disorders. Along with this, the high investment in the medical R&D activities is estimated to boost the segment growth.
Download Sample of This Strategic Report @ https://www.researchnester.com/sample-request-3970
The global cognitive neuroscience market is estimated to grow on the back of growing prevalence of mental disorders, such as, Parkinson’s disease, dementia, and Alzheimer’s disease. According to the data by the World Health Organization (WHO), more than 55 million people live with dementia worldwide, while nearly 10 million new cases are reported every year. Moreover, the growing demand for new treatment approaches, such as, combination of psychology and neuroscience, is further estimated to drive the market growth.
On the basis of geographical analysis, the global cognitive neuroscience market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period on account of growing prevalence of mental diseases, such as, dementia, in the region. According to the data by the Alzheimer’s Association, estimated 6.2 million Americans, aged 65 and older are living with Alzheimer’s dementia, as in 2021.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Request a Sample Copy of Concerned Market Report @ https://www.researchnester.com/sample-request-3970
Increasing Need for Advanced Treatment Methods for Mental Diseases to boost the Market Growth
Mental disorders can be complicated, and one treatment method may not be equally effective for every patient. Therefore, cognitive neuroscience uses a combination of both psychology, and neurology to obtain maximum positive results for patients. This is expected to boost the market growth. Moreover, rising awareness amongst patients about advanced technologies, is further estimated to boost the market growth.
However, non-availability of cognitive neuroscience in the underdeveloped and developing regions expected to operate as key restraint to the growth of global cognitive neuroscience market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global cognitive neuroscience market which includes company profiling of Alpha Omega Inc., Judges Scientific Plc, Laserglow Technologies, Biobserve GmbH, Medtronic Plc, Abbot Laboratories, Pear Therapeutics, Inc., Penumbra, Inc., Stryker Corporation, and Boston Scientific Corporation. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global cognitive neuroscience market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Curious about this latest version of report? Obtain Report Details @ https://www.researchnester.com/reports/cognitive-neuroscience-market/3970
About Research Nester
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
Contact Us
AJ Daniel
Email: info@researchnester.com
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]